Go to the profile of BioPharma Dealmakers

BioPharma Dealmakers

 
  • United Kingdom
Go to the profile of Rémi Palmantier
Rémi Palmantier

Consultant and President of ImmThera, ImmThera Consulting SAS

Go to the profile of Lee C. Drinkard, M.D,
Lee C. Drinkard, M.D,

Medical Oncology/Hematology, Lee C. Drinkard, M.D., PLLC

Go to the profile of Seonkyoung LEE
Seonkyoung LEE

BD Manager, KDDF

Go to the profile of HAOJUN LIAN
HAOJUN LIAN

BD, Innovent Biologics

Go to the profile of William Kem
William Kem

Professor at University of Florida, University of Florida

Go to the profile of Jesse Paterson
Jesse Paterson

Director, Business Development, GlycoNet

Go to the profile of Jeff Kent
Jeff Kent

COO, Papercurve

Go to the profile of Simon Loiodice
Simon Loiodice

Research Scientist, CNS Pharmacology, Biotrial

Go to the profile of George Skouras
George Skouras

Managing Partner, Cue Capital LP

Go to the profile of Taewon Yoon
Taewon Yoon

Senior manager of Business development, Yuhan USA

Go to the profile of Conrad Hicks
Conrad Hicks

CEO, Neuralight HD

Go to the profile of James Collins
James Collins

Professor at University of Minnesota, University of Minnesota

Go to the profile of Mohammad Rahbari
Mohammad Rahbari

Student, Heinrich-Heine-University Düsseldorf

Go to the profile of Qi Wang
Qi Wang

CTO, C & J pty ltd

perticular Bio-pharmaceutical Provisional patent 2018900680/Au Title: Pharmaceutical Product and Uses Thereof. International Patent No. PCT/US2017/048943 Title: Monoterpene Compositions and Uses Thereof.
Go to the profile of Davide Franceschini
Davide Franceschini

Drug Discovery Consulting Director, Biology, Selvita S.A.

Go to the profile of Sorush Niknamian
Sorush Niknamian

Cancer Researcher, Liberty university

Go to the profile of Julie Blatt
Julie Blatt

Pysician, University of North Carolina

Go to the profile of Cadex Genomics
Cadex Genomics

Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response

Go to the profile of George Colberg
George Colberg

CEO, Kalos Therapeutics, Inc

Go to the profile of Bjørn Otto Vasbotten
Bjørn Otto Vasbotten

Technical Project Lead at Link Mobility AS, Link Mobility AS